Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.38B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
Amazon
AMZN
|
+$606M |
| 4 |
Walt Disney
DIS
|
+$559M |
| 5 |
AT&T
T
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$1.41B |
| 2 |
Comcast
CMCSA
|
+$658M |
| 3 |
Boston Scientific
BSX
|
+$650M |
| 4 |
Palo Alto Networks
PANW
|
+$642M |
| 5 |
T-Mobile US
TMUS
|
+$577M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.81% |
| 2 | Healthcare | 2.95% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.15% |
| 5 | Industrials | 1.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
10401
CALL
E.W. Scripps
SSP
$303M
| $140K | ﹤0.01% |
17,500
+5,000
| +40% | +$33.6K |
|
10402
Constellium
CSTM
$4.05B
| $140K | ﹤0.01% |
7,004
-49,681
| -88% | -$870K |
|
10403
PUT
Petco
WOOF
$791M
| $140K | ﹤0.01% |
44,200
-75,400
| -63% | -$260K |
|
|
AHRT
10404
AH Realty Trust
AHRT
$504M
| $140K | ﹤0.01% |
11,289
-77,583
| -87% | -$855K |
|
|
GAN
10405
CALL
DELISTED
GAN Ltd
GAN
| $140K | ﹤0.01% |
88,300
-1,000
| -1% | -$1.33K |
|
10406
PUT
Turning Point Brands
TPB
$1.76B
| $139K | ﹤0.01% |
5,300
-1,700
| -24% | -$38.9K |
|
10407
CALL
Integra LifeSciences
IART
$1.36B
| $139K | ﹤0.01% |
+3,200
| New | +$126K |
|
10408
CALL
Selective Insurance
SIGI
$5.61B
| $139K | ﹤0.01% |
1,400
-3,900
| -74% | -$400K |
|
10409
CALL
Heron Therapeutics
HRTX
$60.1M
| $139K | ﹤0.01% |
81,900
+70,600
| +625% | +$77.7K |
|
10410
CALL
Atlanticus Holdings
ATLC
$1.43B
| $139K | ﹤0.01% |
3,600
+2,500
| +227% | +$78.7K |
|
10411
PUT
VirTra
VTSI
$35.6M
| $139K | ﹤0.01% |
14,700
+10,900
| +287% | +$71K |
|
10412
PUT
PennantPark Floating Rate Capital
PFLT
$748M
| $139K | ﹤0.01% |
11,500
+4,500
| +64% | +$49.1K |
|
|
ALPN
10413
CALL
DELISTED
Alpine Immune Sciences Inc
ALPN
| $139K | ﹤0.01% |
7,300
+5,600
| +329% | +$77.8K |
|
10414
PUT
Gladstone Capital
GLAD
$445M
| $139K | ﹤0.01% |
6,500
-5,350
| -45% | -$107K |
|
10415
PUT
Allogene Therapeutics
ALLO
$732M
| $139K | ﹤0.01% |
43,300
+1,600
| +4% | +$4.54K |
|
10416
Culp Inc
CULP
$43.3M
| $139K | ﹤0.01% |
23,981
+8,110
| +51% | +$44.1K |
|
|
LAZR
10417
PUT
DELISTED
Luminar Technologies
LAZR
| $139K | ﹤0.01% |
2,747
-8,140
| -75% | -$405K |
|
10418
PUT
Zegna
ZGN
$3.8B
| $139K | ﹤0.01% |
+12,000
| New | +$143K |
|
10419
PUT
IDEAYA Biosciences
IDYA
$3.58B
| $139K | ﹤0.01% |
3,900
-5,600
| -59% | -$167K |
|
10420
PUT
Bain Capital Specialty
BCSF
$840M
| $139K | ﹤0.01% |
9,200
-3,600
| -28% | -$54.8K |
|
10421
PUT
CEL-SCI Corp
CVM
$26.4M
| $138K | ﹤0.01% |
1,693
-110
| -6% | -$6.85K |
|
10422
PUT
Vaxcyte
PCVX
$8.8B
| $138K | ﹤0.01% |
2,200
| – | – |
|
10423
PUT
Applied Industrial Technologies
AIT
$13.2B
| $138K | ﹤0.01% |
800
-10,300
| -93% | -$1.67M |
|
10424
CALL
Matrix Service
MTRX
$328M
| $138K | ﹤0.01% |
14,100
-8,300
| -37% | -$90.1K |
|
10425
CALL
Terreno Realty
TRNO
$7.48B
| $138K | ﹤0.01% |
2,200
+1,700
| +340% | +$96.7K |
|
Similar funds
Citadel Advisors's Q4 2023 Portfolio in Review
As of Q4 2023, Citadel Advisors held 15,795 positions worth $500B, up 7.2% from $467B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Citadel Advisors withdrew a net $25.4B in Q4 2023, closing 1,625 positions and reducing 6,315 holdings. Its most notable exit was Activision Blizzard, an estimated $1.41B position sold in full.
By sector, the portfolio is most concentrated in Technology at 3.8% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Citadel Advisors opened a new position in iShares iBoxx $ Investment Grade Corporate Bond ETF worth $129M.
- Citadel Advisors's largest Q4 2023 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 1,167,658 shares worth $129M.
- Citadel Advisors added most to State Street SPDR S&P 500 ETF Trust in Q4 2023, an estimated $1.38B increase.
- Citadel Advisors's biggest Q4 2023 reduction was Comcast, cutting an estimated $658M.
- Citadel Advisors fully exited Activision Blizzard in Q4 2023, selling an estimated $1.41B.
- Citadel Advisors's ten largest holdings make up 31% of its $500B portfolio in Q4 2023.
- Citadel Advisors opened 1,585 new positions and closed 1,625 in Q4 2023.
- Citadel Advisors's portfolio value rose 7.2% quarter-over-quarter to $500B.
Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.